Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Major Shareholding Notification 2021

Aug 4, 2021

6965_rns_2021-08-04_90f08752-bc8f-442c-a915-db796b77dbb6.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

SEC Form 3

FORM 3 UNITED STATES SECURITIES AND EXCHANGE

COMMISSION Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number: 3235- 0104

Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*
Rabinowitz Michael
2. Date of Event
Requiring Statement
(Month/Day/Year)
08/01/2021
3. Issuer Name and Ticker or Trading Symbol
ORAMED PHARMACEUTICALS INC.
[ ORMP ]
(Last) (First)
1185 AVENUE OF THE
(Middle) 4. Relationship of Reporting Person(s) to
Issuer
(Check all applicable)
10% Owner
5. If Amendment, Date of Original
Filed (Month/Day/Year)
AMERICAS, THIRD FLOOR
(Street)
NEW
X Director
Officer (give
title below)
Chief Commercial Officer
below) Other (specify X 6. Individual or Joint/Group Filing
(Check Applicable Line)
Form filed by One Reporting
Person
Form filed by More than One
YORK
(City)
NY
(State)
10036
(Zip)
Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 4) 2. Amount of Securities
Beneficially Owned (Instr.
3. Ownership
Form: Direct
(D) or Indirect
(I) (Instr. 5)
4. Nature of Indirect Beneficial
Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and
Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities
Underlying Derivative Security
(Instr. 4)
4.
Conversion
Price of
5.
Ownership
Form:
6. Nature of
Indirect Beneficial
Ownership (Instr.
or Exercise Direct (D) 5)

Explanation of Responses:

No securities are beneficially owned.

/s/ Michael Rabinowitz 08/04/2021

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.